McKesson this week said it appointed Tom Rodgers as executive VP and chief strategy and business development officer, effective June 5.
Upon the appointment, Rodgers will also become a member of the executive operating team. He succeeds Bansi Nagji who stepped down on March 31.
Rodgers will be responsible for the company’s overall strategic plan and initiatives, key acquisitions and internal programs that help drive financial performance and enhanced innovation.
Prior to his new role, Rodgers served as senior VP and managing director for McKesson Ventures. He has more than 25 years of experience working in emerging companies and has held a number of leadership positions at Cambia Health and Advanced Technology Ventures.
“McKesson has a long history of evolving our company in meaningful ways that enable us to lead in a rapidly changing healthcare environment,” CEO Brian Tyler said in a news release. “Tom’s experience in both venture capital and large healthcare environments, will be extremely valuable to our leadership team as we continue to strengthen our core business and transform our company to create new opportunities to deliver future growth.”
Dave Schulte is slated to be Rodger’s successor to lead McKesson Ventures.
